Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

about

Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer's Disease.

P2860

Q38612032-060E8EDF-C1E7-476C-8ECE-5D2B5FABA499 Q41325309-4B1E8365-3C4E-4552-AC26-451865FB9CA4

P2860

Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q38222874

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

@en

type

Item

label

Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

@en

prefLabel

Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

@en

P1476

Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

@en

P2093

Deming Zhao

http://www.w3.org/2001/XMLSchema#string

Lifeng Yang

http://www.w3.org/2001/XMLSchema#string

Yongyao Fu

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein

Alzheimer Disease in the US Population

The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures

Biomarkers and surrogate endpoints

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

The human complement factor H: functional roles, genetic variations and disease associations

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

Identification of oxidized plasma proteins in Alzheimer's disease.

P2888

s12031-014-0356-x

P304

739-747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12031-014-0356-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003994747

http://www.w3.org/2001/XMLSchema#string

P698

24961342

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

about

P2860

P2860

Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921